Longevity Health Holdings, Inc. (XAGE) - Total Assets
Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) holds total assets worth $2.37 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Longevity Health Holdings, Inc. shareholders equity for net asset value and shareholders' equity analysis.
Longevity Health Holdings, Inc. - Total Assets Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s total assets have evolved over time, based on quarterly financial data.
Longevity Health Holdings, Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Longevity Health Holdings, Inc.'s total assets of $2.37 Million consist of 82.4% current assets and 17.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 29.9% |
| Accounts Receivable | $36.50K | 1.5% |
| Inventory | $963.03K | 40.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.09K | 0.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Longevity Health Holdings, Inc. market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Longevity Health Holdings, Inc.'s current assets represent 82.4% of total assets in 2025, an increase from 11.5% in 2021.
- Cash Position: Cash and equivalents constituted 29.9% of total assets in 2025, down from 49.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 40.7% of total assets.
Longevity Health Holdings, Inc. Competitors by Total Assets
Key competitors of Longevity Health Holdings, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Silicon2 Co. Ltd.
KQ:257720
|
Korea | ₩668.12 Billion |
|
Guangdong Marubi Biotechnology Co
SHG:603983
|
China | CN¥4.85 Billion |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
China | CN¥1.12 Billion |
|
Kolmar BNH Co. Ltd
KQ:200130
|
Korea | ₩649.69 Billion |
|
Amorepacific Group
KO:002795
|
Korea | ₩8.54 Trillion |
|
Hankook Cosmet
KO:123690
|
Korea | ₩57.42 Billion |
|
KP Tissue Inc
TO:KPT
|
Canada | CA$71.60 Million |
|
Suominen Oyj
HE:SUY1V
|
Finland | €278.77 Million |
Longevity Health Holdings, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.25 | 0.16 | 9.47 |
| Quick Ratio | 0.12 | 0.14 | 9.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-5.97 Million | $-4.92 Million | $1.01 Million |
Longevity Health Holdings, Inc. - Advanced Valuation Insights
This section examines the relationship between Longevity Health Holdings, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.91 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 60.6% |
| Total Assets | $2.37 Million |
| Market Capitalization | $688.14K USD |
Valuation Analysis
Below Book Valuation: The market values Longevity Health Holdings, Inc.'s assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Longevity Health Holdings, Inc.'s assets grew by 60.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual total assets of Longevity Health Holdings, Inc. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.37 Million | +60.59% |
| 2024-12-31 | $1.47 Million | -97.70% |
| 2023-12-31 | $63.95 Million | +3557.25% |
| 2022-12-31 | $1.75 Million | +12.29% |
| 2021-12-31 | $1.56 Million | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more